Page 2 - Gene Sequencing News Today

And the trump campaign. Wall street and markets watch as President Trump struggles to push through his Healthcare Reforms. Could a 2 trillion bubble be about to burst . Plus australia puts on a song and dance for chinas premier li massive trade ties top of the agenda. Welcome to World Business report. Also, samsun faces shareholders at its annual meeting. Id like to be a Fly On The Wall there. Our our we start in the us where President Trump is battling to deliver on one of his biggest election ...

Commission, jean claude juncker, has told the bbc that the eu will not seek to punish britain during brexit negotiations. Hosni mubarak has been freed after yea rs Hosni Mubarak has been freed after years in detention following his overthrow in the arab Spring Revolution in his country. A warning that bad behaviour in English Schools is not being dealt with properly and pupils performance is being negatively affected. Good morning. Were live At Westminster, where it seems life is returning back ...

The UK government has launched a pilot project to analyse the blood samples of UK stroke patients who experience side effects to understand the roles of genetic influence in stroke prevention

Researchers developed the NOVA algorithm to systematically analyze bacterial isolates unidentified using traditional methods such as matrix-assisted laser desorption ionization-time of flight mass spectrometry and partial 16S rRNA gene sequencing using whole genome sequencing.

One dangerous disease gets passed down from generation to generation, experts say.

The current evidence of the role of gut microbiota in Alzheimer’s disease (AD) pathogenesis.

South Asia News: Nepal on Monday confirmed cases of Omicron sub-variant JN1. In a press release, the Ministry of Health and Population confirmed that seven cases relat

Explore the complexities of limited molecular genotyping availability, the importance of comprehensive testing, and challenges in accessing target therapies, including cost considerations, in real-world clinical practice.

InnovationRx is your weekly digest of healthcare news. Sign up!

Oxford Nanopore Technologies plc secured a £70 million (US$85 million) investment from Biomérieux SA. The investment comes on the back of a partnership formed between the two companies earlier in the year. The funds will support the development of products in Oxford Nanopore’s portfolio to serve in vitro diagnostics (IVD) markets.